Back to Top
Go Back
Journal Photo for BioDrugs
Peer reviewed only Open Access

BioDrugs (BioDrugs)

Publisher : Springer Nature
Pharmacology Medicine Biochemistry
e-ISSN 1179-190X
p-ISSN 1173-8804
Issue Frequency Monthly
Impact Factor 6.8
Est. Year 1997
Mobile 6494770700
Country New Zealand
Language English, Toxicology, Pharmaceutics
APC YES
Impact Factor Assignee Google Scholar
Email customerservice@springernature.com

Journal Descriptions

BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease. The Journal includes: - Definitive reviews on topics relating to the development and use of biotechnology in healthcare and the management of disease. - Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement. - Original research articles on the clinical development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products. - Leading/Current Opinion articles providing an overview of contentious or emerging issues and key regulatory and ethical issues. - Adis Drug Evaluations reviewing the properties and place in therapy of biotechnology-based drugs. - Adis Biosimilar Briefs summarizing key characteristics and clinical use of biosimilar drugs.

BioDrugs (BioDrugs) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Pharmacology, Medicine, Biochemistry, Molecular Biology, Biotechnology , Online or Print , Monthly Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1173-8804, E-ISSN: 1179-190X, Established: 1997, Impact Factor: 6.8
  • Does Not Provide Crossref DOI
  • Indexed in: Scopus, WoS, PubMed, UGC CARE

  • Not indexed in DOAJ

Indexing